Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome (vol 35, pg 520, 2017)

Sorigue M.; Mercadal S.; Alonso S.

首页> 外文期刊>Hematological oncology >Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome (vol 35, pg 520, 2017)

【24h】

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome (vol 35, pg 520, 2017)

机译：滤泡淋巴瘤免疫化学疗法的耐火材料：预测因素和结果（Vol 35，PG 520,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hematological oncology》 |2019年第s2期|共1页
作者
Sorigue M.; Mercadal S.; Alonso S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
入库时间 2022-08-20 08:04:53

相似文献

外文文献
中文文献
专利

1. Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome (vol 35, pg 520, 2017) [J] . Sorigue M., Mercadal S., Alonso S. Hematological oncology . 2019,第S2期

机译：滤泡淋巴瘤免疫化学疗法的耐火材料：预测因素和结果（Vol 35，PG 520,2017）
2. Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome [J] . Sorigue Marc, Mercadal Santiago, Alonso Sara, Hematological oncology . 2017,第4期

机译：滤泡淋巴瘤免疫化学疗法的耐火材料：预测因素和结果
3. Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial (vol 34, pg 2575, 2016) [J] . Sarkozy Journal of Clinical Oncology . 2016,第26期

机译：在PRIMA试验中对一线免疫放疗反应后发生组织学改变的滤泡性淋巴瘤患者的危险因素和结果（第34卷，第2575页，2016年）
4. Predicting lymphoma outcomes and risk factors in patients with primary Sjögren’s Syndrome using gradient boosting tree ensembles [C] . Vasileios C. Pezoulas, Themis P. Exarchos, Athanasios G. Tzioufas, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2019

机译：使用梯度增强树组合预测原发性干燥综合征患者的淋巴瘤结局和危险因素
5. Clinical outcomes and cost-effectiveness of white blood cell growth factors in elderly patients with non -Hodgkin's lymphoma: Findings from a large population-based cohort. [D] . Gruschkus, Stephen K. 2009

机译：非霍奇金淋巴瘤的老年患者的白细胞生长因子的临床结果和成本效益：基于大量人群的研究结果。
6. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation [O] . Gunjan L. Shah, Joachim Yahalom, Matthew J. Matasar, -1

机译：挽救性化疗和自体干细胞移植治疗原发性难治性霍奇金淋巴瘤患者预后的危险因素
7. Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome [O] . 2019

机译：卵泡淋巴瘤免疫化学疗法的耐火材料：预测因素和结果

Refractoriness to immunochemotherapy in follicular lymphoma: Predictive factors and outcome (vol 35, pg 520, 2017)

著录项

相似文献

相关主题

期刊订阅